|
Press Releases |
|
![](http://www.acnnewswire.com/images/company/Lexaria.jpg) |
|
Monday, May 6, 2024 |
|
Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 ("GLP-1") drug, semaglutide, related to its mode of action and performance. more info >> |
|
Tuesday, April 16, 2024 |
|
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study |
Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces approval has been received from an independent third-party ethics review board, for human pilot study #2 (the "Study"), investigating GLP-1 drugs and DehydraTECH. more info >> |
|
Tuesday, April 2, 2024 |
|
Lexaria Awarded New Patents |
more info >> |
|
Thursday, March 14, 2024 |
|
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer |
Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of Nelson Cabatuan, CPA, as Chief Financial Officer (CFO) effective immediately. more info >> |
|
Thursday, March 7, 2024 |
|
Lexaria Awards Contract For Next GLP-1 Human Pilot Study |
Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces it has hired a contract research organization ("CRO") to perform the Company's second DehydraTECH-powered glucagon-like peptide 1 ("GLP-1") human pilot study #2 (the "Study"). more info >> |
|
Tuesday, March 5, 2024 |
|
Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1 |
more info >> |
|
Monday, March 4, 2024 |
|
7% Weight Loss in Animals Supports Lexaria's Next 8-week Animal Study |
more info >> |
|
Friday, March 1, 2024 |
|
Lexaria Announces FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial |
Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW), a global innovator in drug delivery platforms, announces that the U.S. Food and Drug Administration (FDA) has confirmed effectiveness as of February 28, 2024 of the Company's investigational new drug (IND) application thereby cleared for Lexaria to conduct its planned U.S. Phase 1b hypertension clinical trial HYPER-H23-1 utilizing DehydraTECH-CBD. more info >> |
|
Saturday, February 17, 2024 |
|
Lexaria Announces Closing of $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules |
more info >> |
|
|
|
|
|
|
|
|
![](/images/space.gif) |
Latest Press Releases |
![](/images/space.gif) |
Annual fashion spotlight CENTRESTAGE draws more than 8,500 buyers
Sept 7, 2024 20:19 HKT/SGT
|
|
|
TANAKA Precious Metals Announces Executive Appointments
Sept 7, 2024 3:00 JST
|
|
|
Amazfit Launches T-Rex 3, the Ultimate Adventure Companion
Sept 6, 2024 20:00 HKT/SGT
|
|
|
Panasonic Energy and Mazda to Begin Preparation for Supply of Automotive Lithium-ion Batteries
Sept 6, 2024 16:34 JST
|
|
|
GTJAI Receives Multiple Awards in Bond Connect 2024 Awards
Sept 6, 2024 15:32 HKT/SGT
|
|
|
Toyota's Next-Generation BEV Battery Development and Production Plan Certified by METI
Sept 6, 2024 15:10 JST
|
|
|
Reopening of CENTRESTAGE, Hong Kong Watch & Clock Fair and Salon de TIME
Sept 6, 2024 11:10 HKT/SGT
|
|
|
transport logistic and air cargo Southeast Asia: Fueling Regional Economic Growth
Sept 6, 2024 10:09 HKT/SGT
|
|
|
Toyota Motor Corporation and BMW Group Strengthen Collaboration Towards the Advancement of a Hydrogen Society
Sept 6, 2024 9:26 JST
|
|
|
How Much Do Vegan Diets Improve the Health of Dogs?
Sept 6, 2024 07:00 HKT/SGT
|
|
|
Taiwan Excellence Unveils Pioneering Medtech Innovation at Medical Fair Asia 2024
Sept 5, 2024 23:00 HKT/SGT
|
|
|
Lexaria Releases Strategic Letter from the Outgoing CEO
Sept 5, 2024 22:00 HKT/SGT
|
|
|
Betting Big on Content: CMGE Steers Through Industry Waves with Robust Lineup
Sept 5, 2024 22:00 HKT/SGT
|
|
|
Cambridge Isotope Laboratories, Inc. Expands 13C Production Capacity With North Star Project
Sept 5, 2024 21:00 HKT/SGT
|
|
|
Lexaria Welcomes Industry Veteran as New CEO
Sept 5, 2024 21:00 HKT/SGT
|
|
|
|
More Press release >> |
|
|
![](/images/space.gif) |
![](/images/space.gif) |
![](/images/space.gif) |
|
|